HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism.

Abstract
Irisin is a myokine involved in the browning of white adipose tissue and regulation of energy expenditure, glucose homeostasis and insulin sensitivity. Debated evidence exists on the metabolic role played by irisin in children with overweight or obesity, while few information exist in children with Prader Willi Syndrome (PWS), a condition genetically prone to obesity. Here we assessed serum irisin in relation to the metabolic profile and body composition in children and adolescents with and without PWS. In 25 PWS subjects [age 6.6-17.8y; body mass index standard deviation score (BMI SDS) 2.5 ± 0.3] and 25 age, and BMI-matched controls (age 6.8-18.0y; BMI SDS, 2.8 ± 0.1) we assessed irisin levels and metabolic profile inclusive of oral glucose tolerance test (OGTT), and body composition by dual-energy X-ray absorptiometry (DXA). In PWS, we recorded lower levels of fat-free mass (FFM) (p <0.05), fasting (p<0.0001) and 2h post-OGTT insulin (p<0.05) and lower insulin resistance as expressed by homeostatic model of insulin resistance (HOMA-IR) (p<0.0001). Irisin levels were significantly lower in PWS group than in controls with common obesity (p<0.05). In univariate correlation analysis, positive associations linked irisin to insulin OGTT0 (p<0.05), insulin OGTT120 (p<0.005), HOMA-IR (p<0.05) and fasting C-peptide (p<0.05). In stepwise multivariable regression analysis, irisin levels were independently predicted by insulin OGTT120. These results suggest a link between irisin levels and insulin sensitivity in two divergent models of obesity.
AuthorsStefania Mai, Danilo Fintini, Chiara Mele, Alessio Convertino, Sarah Bocchini, Graziano Grugni, Gianluca Aimaretti, Roberta Vietti, Massimo Scacchi, Antonino Crinò, Paolo Marzullo
JournalFrontiers in endocrinology (Front Endocrinol (Lausanne)) Vol. 13 Pg. 918467 ( 2022) ISSN: 1664-2392 [Print] Switzerland
PMID35774143 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022 Mai, Fintini, Mele, Convertino, Bocchini, Grugni, Aimaretti, Vietti, Scacchi, Crinò and Marzullo.
Chemical References
  • Blood Glucose
  • FNDC5 protein, human
  • Fibronectins
  • Insulin
  • Glucose
Topics
  • Adolescent
  • Blood Glucose (metabolism)
  • Child
  • Fibronectins (blood, metabolism)
  • Glucose (metabolism)
  • Humans
  • Insulin (blood)
  • Insulin Resistance (physiology)
  • Obesity (blood)
  • Prader-Willi Syndrome (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: